Whole-genome sequencing of samples from patients with myeloid malignancies can enable more accurate risk stratification than is possible with conventional cytogenetics. Research by Duncavage et al. demonstrates that such an approach can now be delivered within several days using a highly streamlined and automated workflow.

中文翻译：

---

骨髓疾病的全基因组测序：一种将它们全部分层的分析方法？

与传统细胞遗传学相比，对骨髓恶性肿瘤患者样本进行全基因组测序可以实现更准确的风险分层。Duncavage 等人的研究。表明现在可以使用高度简化和自动化的工作流程在几天内交付这种方法。